MAPT and tauopathy: For FTLD driven by tau, the 4R tauopathy CBD appears to be the one showing the most frequent participation of TDP-43 in ∼16% of neuropathological cases in some series (Uryu et al., 2008; Uryu et al., 2008; Kim et al., 2018).